1. Home
  2. VKTX vs INSP Comparison

VKTX vs INSP Comparison

Compare VKTX & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • INSP
  • Stock Information
  • Founded
  • VKTX 2012
  • INSP 2007
  • Country
  • VKTX United States
  • INSP United States
  • Employees
  • VKTX N/A
  • INSP N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • INSP Medical/Dental Instruments
  • Sector
  • VKTX Health Care
  • INSP Health Care
  • Exchange
  • VKTX Nasdaq
  • INSP Nasdaq
  • Market Cap
  • VKTX 3.5B
  • INSP 3.8B
  • IPO Year
  • VKTX 2015
  • INSP 2018
  • Fundamental
  • Price
  • VKTX $26.98
  • INSP $86.41
  • Analyst Decision
  • VKTX Strong Buy
  • INSP Buy
  • Analyst Count
  • VKTX 13
  • INSP 15
  • Target Price
  • VKTX $86.92
  • INSP $165.86
  • AVG Volume (30 Days)
  • VKTX 9.7M
  • INSP 1.0M
  • Earning Date
  • VKTX 10-22-2025
  • INSP 11-03-2025
  • Dividend Yield
  • VKTX N/A
  • INSP N/A
  • EPS Growth
  • VKTX N/A
  • INSP 756.73
  • EPS
  • VKTX N/A
  • INSP 1.74
  • Revenue
  • VKTX N/A
  • INSP $861,312,000.00
  • Revenue This Year
  • VKTX N/A
  • INSP $14.93
  • Revenue Next Year
  • VKTX N/A
  • INSP $14.34
  • P/E Ratio
  • VKTX N/A
  • INSP $49.79
  • Revenue Growth
  • VKTX N/A
  • INSP 22.05
  • 52 Week Low
  • VKTX $18.92
  • INSP $73.92
  • 52 Week High
  • VKTX $81.73
  • INSP $225.00
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 41.03
  • INSP 36.72
  • Support Level
  • VKTX $26.13
  • INSP $83.76
  • Resistance Level
  • VKTX $28.26
  • INSP $97.25
  • Average True Range (ATR)
  • VKTX 1.63
  • INSP 4.11
  • MACD
  • VKTX -0.39
  • INSP 1.02
  • Stochastic Oscillator
  • VKTX 19.82
  • INSP 19.68

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About INSP Inspire Medical Systems Inc.

Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Share on Social Networks: